PTGS2 and Kaposi's sarcoma: This is supported by findings showing that vGPCR activates COX-2 in endothelial cells [41], that KSHV de novo infection upregulates COX-2 [31–33,35] and that KSHV-infected malignant cells of human KS lesions express COX-2.